New Treatments for SLE? Dr. Petri discusses abstract 1117 presented at #ACR22. Efficacy & Safety of Deucravacitini
Tweet Content
New Treatments for SLE?
Dr. Petri discusses abstract 1117 presented at #ACR22. Efficacy & Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients w/Active SLE: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study https://t.co/O25Fd8B4dT https://t.co/bbuzaiEb8h
Show on Archive Page
On
Display in Search Results
On
PDQ
Off